NASDAQ
Achilles Therapeutics plc (ACHL) has a fcf yield of -139.43% as of Friday, May 29, 2026. This represents a 48.33% decrease compared to its 12-month average of -94.00%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.